NMPA Approval

Pediatric Compound Sulfamethoxazole Granules

Approval Number

国药准字H61023265

Company陕西大生制药科技有限公司

Registration Date

September 22, 2021

Previous Approval Numbers

国药准字H61023265

Drug Information

Generic Name

小儿复方磺胺甲噁唑颗粒

Dosage Form

颗粒剂

Strength

磺胺甲噁唑0.1g、甲氧苄啶20mg

Drug Type

化学药品

Registration Date

September 22, 2021

Company Information

Applicant Company

Company Name陕西大生制药科技有限公司

Company Address

西安市高新区沣惠南路2号枫叶新都市杰座广场九楼

Manufacturing Company

Company Name陕西大生制药科技有限公司

Company Address

西安市灞桥区田洪正街1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

小儿复方磺胺甲噁唑颗粒 - NMPA 批准文号 | MedPath